PulmoJet®

Sanofi Generics

With the creation of Sanofi Generics, Sanofi strengthens its commitment to provide patients around the world, reliable access to valuable and affordable high-quality, safe and effective medicines. In addition to being effective therapies, generic medicines also play an important role by enabling health care systems to invest savings in the development of future, innovative treatments. Sanofi Generics operates worldwide using already strong generics brands like Zentiva, Medley, Genfar, Winthrop and Globalpharma with about 700 INN and selling 900 M boxes per year that represents more than 20 billion standard units. Because patients are at the heart of our approach, every day, women and men who are working for Sanofi Generics strive to identify and fulfill patients‘ needs. Sanofi Generics is using innovation and adapted business models all over the world to make affordable, high quality generic medicines available to patients and to develop strategic partnership with healthcare management stakeholders. The mission of the global Generics Franchise is to complement Sanofi’s offering to patients by selecting, developing and manufacturing a portfolio of competitive generic products to maximize growth opportunities, synergistic with the overall footprint of Sanofi within key geographies. With its generics products, Sanofi strengthens its commitment to provide reliable access to valuable and affordable high-quality, safe and effective medicines. In addition to being effective therapies, generic medicines also play an important role by enabling health care systems to invest savings in the development of future, innovative treatments. Sanofi Generics operates worldwide using already strong generic brands like Zentiva, Medley, Genfar, Winthrop and Globalpharma.